Drug
Xanomeline
Xanomeline: highest development phase Phase 1, developed by Karuna Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Karuna Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| xanomeline tartrate NCT02831231 | Phase 1 | Schizophrenia |
Latest
No recent events.
Follow Xanomeline on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.